Poway, CA, September 6, 2022 — Cellipont Bioservices, a contract development and manufacturing organization (CDMO) specializing in cell therapies and gene-modified cell therapies, today announced the addition of Stella Vnook as Chief Scientific Officer.
“Stella brings to Cellipont decades of scientific experience in cell therapies. Her expertise will be a great asset for the clients we support, as well as for our internal teams. In addition, with Stella’s past success in both large organizations and as a biotech entrepreneur, she has lived through the challenges our clients face every day. We look forward to her sharing that experience as we move forward,” said Cellipont President & CEO Deborah Wild.